Meta-analysis of prospective studies on the effects of nut consumption on hypertension and type 2 diabetes mellitus

Journal of Diabetes

Volumn 7, Issue 2, 2015, Pages 202-212

  Guo, Kai ^a   Zhou, Zhiwen ^a   Jiang, Yibo ^a   Li, Wei ^a   Li, Yigang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hypertension; Meta analysis; Nut consumption; Type 2 diabetes mellitus

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONSUMER; FOOD INTAKE; HUMAN; HYPERTENSION; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NUT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; RISK FACTOR; DIABETES MELLITUS, TYPE 2; FACTUAL DATABASE; INCIDENCE; META ANALYSIS; PROGNOSIS; RISK REDUCTION;

DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; INCIDENCE; NUTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR;

EID: 84924209228     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12173     Document Type: Article

References (48)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 4-14.
2. Pan WH, Cedres LB, Liu K etal. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol. 1986; 123: 504-516.
3. Stolarz-Skrzypek K, Bednarski A, Czarnecka D, Kawecka-Jaszcz K, Staessen JA. Sodium and potassium and the pathogenesis of hypertension. Curr Hypertens Rep. 2013; 15: 122-130.
4. Molmen-Hansen HE, Stolen T, Tjonna AE etal. Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients. Eur J Prev Cardiol. 2012; 19: 151-160.
5. Tsioufis C, Kasiakogias A, Tsiachris D etal. Metabolic syndrome and exaggerated blood pressure response to exercise in newly diagnosed hypertensive patients. Eur J Prev Cardiol. 2012; 19: 467-473.
6. Tuomilehto J, Lindstrom J, Eriksson JG etal. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344: 1343-1350.
7. Knowler WC, Barrett-Connor E, Fowler SE etal. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403.
8. Rahman K, Lowe GM. Garlic and cardiovascular disease: A critical review. J Nutr. 2006; 136: 736S-740.
9. Phillips KM, Ruggio DM, Ashraf-Khorassani M. Phytosterol composition of nuts and seeds commonly consumed in the United States. J Agric Food Chem. 2005; 53: 9436-9445.
10. Steffen LM, Kroenke CH, Yu X etal. Associations of plant food, dairy product, and meat intakes with 15-y incidence of elevated blood pressure in young black and white adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2005; 82: 1169-1177.
11. Djousse L, Rudich T, Gaziano JM. Nut consumption and risk of hypertension in US male physicians. Clin Nutr. 2009; 28: 10-14.
12. Martinez-Lapiscina EH, Pimenta AM, Beunza JJ, Bes-Rastrollo M, Martinez JA, Martinez-Gonzalez MA. Nut consumption and incidence of hypertension: The SUN prospective cohort. Nutr Metab Cardiovasc Dis. 2010; 20: 359-365.
13. Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA. 2002; 288: 2554-2560.
14. Parker ED, Harnack LJ, Folsom AR. Nut consumption and risk of type 2 diabetes. JAMA. 2003; 290: 38-39; author reply 39-40.
15. Montonen J, Jarvinen R, Heliovaara M, Reunanen A, Aromaa A, Knekt P. Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr. 2005; 59: 441-448.
16. Villegas R, Gao YT, Yang G etal. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr. 2008; 87: 162-167.
17. Kochar J, Gaziano JM, Djousse L. Nut consumption and risk of type II diabetes in the Physicians' Health Study. Eur J Clin Nutr. 2010; 64: 75-79.
18. Pan A, Sun Q, Manson JE, Willett WC, Hu FB. Walnut consumption is associated with lower risk of type 2 diabetes in women. J Nutr. 2013; 143: 512-518.
19. Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012.
20. Alvarez Leon E, Henriquez P, Serra-Majem L. Mediterranean diet and metabolic syndrome: A cross-sectional study in the Canary Islands. Public Health Nutr. 2006; 9: 1089-1098.
21. Ibarrola-Jurado N, Bullo M, Guasch-Ferre M etal. Cross-sectional assessment of nut consumption and obesity, metabolic syndrome and other cardiometabolic risk factors: The PREDIMED study. PLoS ONE. 2013; 8: e57367.
22. Wells GA, Shea B, O'Connell D etal. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 15 June 2012).
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188.
24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1101.
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560.
26. Estruch R, Martinez-Gonzalez MA, Corella D etal. Effects of a Mediterranean-style diet on cardiovascular risk factors: A randomized trial. Ann Intern Med. 2006; 145: 1-11.
27. Virtanen JK, Nyantika AN, Kauhanen J, Voutilainen S, Tuomainen TP. Serum long-chain n-3 polyunsaturated fatty acids, methylmercury and blood pressure in an older population. Hypertens Res. 2012; 35: 1000-1004.
28. Cabo J, Alonso R, Mata P. Omega-3 fatty acids and blood pressure. Br J Nutr. 2012; 107 (Suppl. 2): S195-200.
29. Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr. 2006; 83: 1526S-1535.
30. Kris-Etherton PM, Zhao G, Binkoski AE, Coval SM, Etherton TD. The effects of nuts on coronary heart disease risk. Nutr Rev. 2001; 59: 103-111.
31. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: A meta-analysis. Eur J Clin Nutr. 2012; 66: 411-418.
32. Streppel MT, Arends LR, van 't Veer P, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure: A meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005; 165: 150-156.
33. Lei J, Vodovotz Y, Tzeng E, Billiar TR. Nitric oxide, a protective molecule in the cardiovascular system. Nitric Oxide. 2013; 35: 175-185.
34. Vasdev S, Stuckless J. Antihypertensive effects of dietary protein and its mechanism. Int J Angiol. 2010; 19: e7-e20.
35. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012; 142: 1304-1313.
36. Hruby A, Meigs JB, O'Donnell CJ, Jacques PF, McKeown NM. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged americans. Diabetes Care. 2014; 37: 419-427.
37. Liu HQ, Qiu Y, Mu Y etal. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats. Nutr Res. 2013; 33: 849-858.
38. Salvini S, Hunter DJ, Sampson L etal. Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol. 1989; 18: 858-867.
39. Colditz GA, Martin P, Stampfer MJ etal. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986; 123: 894-900.
40. Qin X, Jackson R, Marshall R etal. Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China. Eur J Cardiovasc Prev Rehabil. 2009; 16: 96-101.
41. Sanchez-Villegas A, Bes-Rastrollo M, Martinez-Gonzalez MA, Serra-Majem L. Adherence to a Mediterranean dietary pattern and weight gain in a follow-up study: The SUN cohort. Int J Obes (Lond). 2006; 30: 350-358.
42. Bes-Rastrollo M, Wedick NM, Martinez-Gonzalez MA, Li TY, Sampson L, Hu FB. Prospective study of nut consumption, long-term weight change, and obesity risk in women. Am J Clin Nutr. 2009; 89: 1913-1919.
43. Torabian S, Haddad E, Rajaram S, Banta J, Sabate J. Acute effect of nut consumption on plasma total polyphenols, antioxidant capacity and lipid peroxidation. J Hum Nutr Diet. 2009; 22: 64-71.
44. Cohen AE, Johnston CS. Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A(1c) in individuals with well-controlled type 2 diabetes mellitus. Metabolism. 2011; 60: 1312-1317.
45. Li SC, Liu YH, Liu JF, Chang WH, Chen CM, Chen CY. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism. 2011; 60: 474-479.
46. Lovejoy JC, Most MM, Lefevre M, Greenway FL, Rood JC. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr. 2002; 76: 1000-1006.
47. Altorf-van der Kuil W, Engberink MF, van Rooij FJ etal. Dietary protein and risk of hypertension in a Dutch older population: The Rotterdam study. J Hypertens. 2010; 28: 2394-2400.
48. Banel DK, Hu FB. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: A meta-analysis and systematic review. Am J Clin Nutr. 2009; 90: 56-63.